4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 64 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $77,000 | +14.9% | 9,600 | 0.0% | 0.01% | +28.6% |
Q2 2022 | $67,000 | -53.8% | 9,600 | 0.0% | 0.01% | +16.7% |
Q1 2022 | $145,000 | -31.3% | 9,600 | -0.2% | 0.01% | 0.0% |
Q4 2021 | $211,000 | -18.5% | 9,621 | 0.0% | 0.01% | -82.9% |
Q3 2021 | $259,000 | +11.6% | 9,621 | 0.0% | 0.04% | 0.0% |
Q2 2021 | $232,000 | -44.2% | 9,621 | +0.2% | 0.04% | -37.5% |
Q1 2021 | $416,000 | – | 9,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 831,267 | $22,419,000 | 5.52% |
Aquilo Capital Management, LLC | 1,099,944 | $29,665,000 | 5.39% |
BVF INC/IL | 2,005,862 | $54,098,000 | 2.11% |
Casdin Capital, LLC | 1,115,455 | $30,084,000 | 0.75% |
Soleus Capital Management, L.P. | 120,900 | $3,261,000 | 0.51% |
Eagle Health Investments LP | 57,090 | $1,540,000 | 0.49% |
Centiva Capital, LP | 358,863 | $7,220,000 | 0.45% |
VIKING GLOBAL INVESTORS LP | 3,937,914 | $106,206,000 | 0.29% |
ArrowMark Colorado Holdings LLC | 1,003,447 | $27,063,000 | 0.21% |
Perceptive Advisors | 375,256 | $10,121,000 | 0.15% |